BioUsawa.png
Bio Usawa Names Former Ghana Food and Drug Authority Director Eric Karikari-Boateng as Head of Global Regulatory Strategy
December 17, 2024 10:15 ET | Bio Usawa Inc
Bio Usawa, Inc., a company committed to delivering affordable biotherapies in Africa, named Eric Karikari-Boateng its Head of Global Regulatory Strategy
Rwanda Minister of State for Health, Yvan Butera, received Sabin’s investigational vaccine
Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak
October 31, 2024 14:22 ET | Sabin Vaccine Institute
Photo caption: Rwanda Minister of State for Health, Yvan Butera, was among those who received Sabin’s investigational vaccine in the open-label clinical trial. WASHINGTON, Oct. 31, 2024 (GLOBE...
Sabin Vaccine Institute Marburg Vaccines Arrive in Rwanda
Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda
October 05, 2024 18:24 ET | Sabin Vaccine Institute
[Caption] Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024. WASHINGTON, Oct. 05, 2024 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has provided...
Picture3
NANO Nuclear Signs a Memorandum of Understanding with the Rwanda Atomic Energy Board to Develop a Robust Nuclear Energy Ecosystem within the Republic of Rwanda
August 15, 2024 13:22 ET | NANO Nuclear Energy Inc.
NANO Nuclear and the Rwanda Atomic Energy Board will cooperate on educational, regulatory and physical development of the country’s nuclear energy infrastructure. New York, N.Y., Aug. 15, 2024 ...
BioNTech und CEPI er
BioNTech und CEPI erweitern Partnerschaft zur Stärkung des afrikanischen mRNA-Impfstoff-Ökosystems
May 29, 2024 08:00 ET | BioNTech SE
  BioNTech und die Coalition for Epidemic Prepardness Innovations (CEPI) wollen die lokale Forschung und Entwicklung sowie die klinische und kommerzielle Herstellung potenzieller mRNA-Impfstoffe...
BioNTech and CEPI Ex
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
May 29, 2024 08:00 ET | BioNTech SE
BioNTech and CEPI aim to enhance local R&D, clinical and commercial-scale manufacturing capacities to develop potential mRNA vaccines in Africa, for AfricaCEPI to fund up to $145 million to...
BioNTech erreicht Me
BioNTech erreicht Meilenstein in der Errichtung einer Produktionsstätte für mRNA-basierte Impfstoffe in Ruanda
December 18, 2023 13:15 ET | BioNTech SE
Die Errichtung des ersten BioNTainers als Hightech-Produktionslösung für mRNA-Arzneimittel ist ein entscheidender Schritt zum Aufbau eines resilienten Impfstoff-Ökosystems in Afrika sowie in der...
BioNTech Achieves Mi
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
December 18, 2023 13:15 ET | BioNTech SE
Set-up of first BioNTainer as high-tech manufacturing solution for mRNA medicines is a critical step in establishing a resilient vaccine ecosystem in Africa and future pandemic preparednessBioNTech...
BioNTech weiht am 18
BioNTech weiht am 18. Dezember 2023 ersten afrikanischen Standort ein
December 12, 2023 06:45 ET | BioNTech SE
MAINZ, Deutschland, 12. Dezember 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Montag, den 18. Dezember 2023, den ersten afrikanischen Standort des...
BioNTech to Inaugura
BioNTech to Inaugurate First African Site on December 18, 2023
December 12, 2023 06:45 ET | BioNTech SE
MAINZ, Germany, December 12, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will inaugurate its first African site in Kigali, Rwanda, on Monday, December 18th, 2023....